-
1 Comment
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited is currently in a long term uptrend where the price is trading 21.0% above its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's total revenue sank by 9.3% to $2B since the same quarter in the previous year.
Its net income has increased by 2.4% to $185M since the same quarter in the previous year.
Finally, its free cash flow grew by 1223.0% to $206M since the same quarter in the previous year.
Based on the above factors, Tianjin Zhong Xin Pharmaceutical Group Corporation Limited gets an overall score of 4/5.
| ISIN | None |
|---|---|
| Exchange | SG |
| CurrencyCode | USD |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 40.% |
|---|---|
| Market Cap | 4B |
| PE Ratio | 4.9 |
| Target Price | 1.84 |
| Beta | 0.78 |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for T14.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
